{
    "nct_id": "NCT03109041",
    "official_title": "Initial Feasibility Study to Treat Resectable Pancreatic Cancer With the Permanently Implantable LDR CivaSheetÂ®",
    "inclusion_criteria": "* Subject signed informed consent\n* Age >/= 18 years\n* Biopsy confirmed adenocarcinoma pancreatic cancer\n* Patient capable of undergoing anesthesia\n* Patient is a surgical candidate\n* Patient selected to undergo pancreatic cancer resection\n* Patient will have known or suspected close/positive surgical margin\n* Confirmed diagnosis of resectable pancreatic adenocarcinoma\n* Will be prescribed standard Gemcitabine 1000 mg/m2 chemotherapy cycle\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Pregnant or breast feeding\n* Patient has metastatic disease\n* Patient has had prior radiation therapy to the region for separate cancer\n* Patient has had prior chemotherapy\n* Any other invasive cancer in the past 5 years, except basal cell skin\n* Recurrent or previously resected tumors\n* Alcoholism/Drug abuse",
    "miscellaneous_criteria": ""
}